Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2005

Restelli M, Grinstein S, Gattuso P, M Preciado V, Brunzini MA, Zarate J, et al. Immunolocalization of the Epstein-Barr nuclear antigen-1 in conjunctival squamous carcinomas and dysplasias. Hum Pathol. 2005;36(4):325-9.

Alvarez JV, Febbo PG, Ramaswamy S, Loda M, Richardson A, Frank DA. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors. Cancer Res. 2005;65(12):5054-62.

Tamburini BA, Tyler JK. Localized histone acetylation and deacetylation triggered by the homologous recombination pathway of double-strand DNA repair. Mol Cell Biol. 2005;25(12):4903-13.

Ghinoi A, Mascia MT, Giuggioli D, Magistro R, Barbolini G, Magro CM, et al. Coexistence of non-specific and usual interstitial pneumonia in a patient with severe cystic scleroderma lung involvement and parvovirus B19 infection. Clin Exp Rheumatol. 2005;23(3):431-3.

Koutlas IG, Pambuccian SE, Jessurun J, J Manivel C, Gopalakrishnan R. Perivascular epithelioid cell tumor of the oral mucosa. Arch Pathol Lab Med. 2005;129(5):690-3.

Li Z, Paik J-, Paik J-, Wang Z, Hla T, Wu D. Role of guanine nucleotide exchange factor P-Rex-2b in sphingosine 1-phosphate-induced Rac1 activation and cell migration in endothelial cells. Prostaglandins Other Lipid Mediat. 2005;76(1-4):95-104.

Ogino S, Kawasaki T, Brahmandam M, Yan L, Cantor M, Namgyal C, et al. Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn. 2005;7(3):413-21.

Gorlova O, Peng B, Yankelevitz D, Henschke C, Kimmel M. Estimating the growth rates of primary lung tumours from samples with missing measurements. Stat Med. 2005;24(7):1117-34.

Trocciola SM, Hoda S, Osborne MP, Christos PJ, Levin H, Martins D, et al. Do bone marrow micrometastases correlate with sentinel lymph node metastases in breast cancer patients? J Am Coll Surg. 2005;200(5):720-5; discussion 725-6.

Chiarle R, Simmons WJ, Cai H, Dhall G, Zamò A, Raz R, et al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med. 2005;11(6):623-9.